Combination of chronic kidney disease with chronic non-infectious diseases

The scientific review examines chronic kidney disease (CKD) in combination with chronic non-communicable diseases. Chronic kidney disease is a serious and growing public health problem worldwide, characterized by a gradual and irreversible decline in kidney function and is one of the leading causes of death worldwide. The priority task of healthcare is the prevention of chronic non-communicable diseases, among which the most significant include cardiovascular diseases, bronchopulmonary diseases, diabetes mellitus, and oncological diseases. The association of CKD with chronic non-communicable diseases, in particular with cardiovascular diseases, makes this pathology especially dangerous, which leads to a deterioration in the quality of life of patients and an increase in mortality. The treatment of patients with comorbid pathology requires a comprehensive and interdisciplinary approach.

1. Standards of Specialized Diabetes Care / Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov 11th Edition // Diabetes mellitus. 2023. Vol.26. No.2S. P.1-157. DOI: 10.14341/DM13042

2. Arterial hypertension and chronic kidney disease: consensus on patient management / I.E. Chazova, O.A. Kislyak, V.I. Podzolkov [et al.] //systemic Hypertension. 2023. Vol.20. No.1. Р.5-19. DOI: 10.38109/2075-082X-2023-1-5-19

3. Bagriy A.E., Khomenko M.V., Shverova O.I. Diabetic nephropathy: issues of epidemiology, terminology, pathogenesis, clinical picture and treatment tactics // Crimean Therapeutic Journal. 2022. No.1. P.15-20.

4. Bakina AA, Pavlenko VI, Naryshkina St. Comprehensive assessment of the functional state of the kidneys in patients with chronic obstructive pulmonary disease //siberian Medical Review. 2020. No. 2. Р.45-51. DOI: 10.20333/2500136-2020-2-45-51

5. Zhaybergenova Zh. B., Abdirashitova G. S., Ametova A. S. Chronic renal failure as a complication of hypertension. Economy and Society. 2021. Vol.1. No.1 (80) Accessed March 4, 2025. https://sciup.org/hronicheskaja-pochechnaja-nedostatochnost-kak-oslozhnenie-gipertonicheskoj-140260254

6. Clinical and pathogenetic aspects of the formation of chronic kidney disease in chronic obstructive pulmonary disease / I.T. Murkamilov, I.S. Sabirov, V.V. Fomin [et al.] // The Scientific Heritage. 2020. No 55. Р.18-26. URL: https://cyberleninka.ru/article/n/kliniko-patogeneticheskie-aspekty-formirovaniya-hronicheskoy-bolezni-pochek-pri-hronicheskoy-obstruktivnoy-bolezni-legkih (дата обращения: 10.03.2025).

7. Clinical recommendations of the Russian Association of Endocrinologists. Type 2 diabetes mellitus in adults. / I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov [et al.]// Russian Association of Endocrinologists. 2022.

8. An integrated approach to the diagnosis of ischemic heart disease in young people / A.I. Belida, A.D. Tikhomirova, E.G. Kipina [et al.] // Bulletin of the National Medical and Surgical Center named after N.I. Pirogov. 2024. Vol. 19, No. 1. P. 93-98. DOI: 10.25881/20728255-2024-19-1-93.

9. Kuz'min O. B. Chronic kidney disease and cardiovascular system // Nephrology. 2007. Vol.11. No. 1. P.28-37. DOI: 10.24884/1561-62742007-11-1-28-37

10. Mineev V.N., Vasil'eva T.S., Deev D.M. Is there a risk of developing chronic kidney disease in patients with bronchial asthma? // Nephrology. 2021. No.4. P.40-47. DOI:10.24884/1561-6274-2017-21-4-40-47

11. Patients with arterial hypertension and chronic kidney disease as a priority group for primary prevention programs /E.A. Medvedeva, E.I. Usova, A.E. Solov'eva [et al.] // Russian Journal of Cardiology. 2024. Vol.29. No.3:5812. DOI: 10.15829/1560-4071-2024-5812.

12. Patients with coronary heart disease and chronic kidney disease the possibility of using a cell adhesion molecule as a predictor of the progression of cardiovascular diseases / A.S. Samakaev, S. E. Glova, E.E. Zimoveiskaya [et al.] //south Russian Journal of Therapeutic Practice. 2023. Vol. 4. No. 2. Р.56-63. DOI: 10.21886/2712-8156 2023-4-2-56-63

13. Practical recommendations for the correction of nephrotoxicity of antitumor drugs /E.G. Gromova, L.S. Biryukova, B.T. Dzhumabaeva [et al.] // Malignant Tumors. 2021. Vol.11. No.3s2-2. P.132–144. DOI:10.18027/2224-5057-2021-113s2-46

14. Prevention of chronic non-communicable diseases in the Russian Federation. National Leadership 2022 /O.M. Drapkina, A.V. Koncevaya, A.M. Kalinina [et al.]// Cardiovascular therapy and prevention. 2022. Vol.21. No.4:3235. DOI:10.15829/1728-8800-2022-3235.

15. The role of advanced glycation end products in the pathogenesis of diabetic nephropathy /A.O. Gavrilova, A.S. Severina, M.Sh. Shamkhalova [et al.] // Diabetes Mellitus. 2021. Vol.24. No.5. P.461-469. DOI: 10.14341/DM12784

16. Diabetes mellitus with kidney damage. Clinical guidelines of the Russian Federation 2013-2017 (Russia) / Russian Association of Endocrinologists. Approved by the Ministry of Health of the Russian Federation 2016 // 2016. The link is active on 04/09/2025. https://diseases.medelement.com/disease/сахарный-диабет-с-поражениемпочек-кр-рф-2016/16692

17. Stable ischemic heart disease. Clinical guidelines 2024 / O.L. Barbarash, Yu.A. Karpov, A.V. Panov [et al.] // Russian Cardiology Journal. 2024. Vol. 29. No. 9. P. 166-229. DOI: 10.15829/1560-4071-2024-6110

18. Khalilova F. A. Comorbid changes in the kidneys and heart in patients with chronic heart failure // Ta'lim va Rivojlanish Tahlili Onlayn Ilmiy Jurnali. 2023. Vol.3. No.5. Р. 524-529.

19. Khvatova, Yu. G., Chernyshev A. V. Risk factors and prevention of ischemic heart disease. Tambov Medical Journal. 2024. Vol.6. No.2. P. 92-107. (In Russian) DOI: 10.20310/2782-5019-2024-6-2-92-107.

20. Chronic kidney disease (CKD). Clinical Guidelines 2024 / National Association of Nephrologists. 2024-2025-2026 (11/19/2024) – Approved by the Ministry of Health of the Russian Federation // 2024. 242 p.

21. Chronic Kidney Disease and Arterial Hypertension: How to Break the Vicious Cycle?/Ebzeeva E.Yu., De V.A., Ni L.I.[et al.] // Russian Medical Journal. 2022. No.5. Р.30-34.

22. Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy /E.M. Mezhonov, O.M. Reytblat, Yu. A. Vyalkina [et al.] // Therapeutic Archives. 2024. No.7. Р.666–674. DOI: 10.26442/00403660.2024.07.202781.

23. Chronic kidney disease and malignant neoplasms: current state of the problem /I.T. Murkamilov, I.S. Sabirov, V.V. Fomin [et al.] // Archives of Internal Medicine. 2022. Vol.12. No.2. P.104–112. DOI:10.20514/2226-6704-2021-12-2-104-112

24. Chronic heart failure. Clinical guidelines 2024 /A.S. Galyavich, S.N. Tereshchenko, T.M. Uskach [et al.] // Russian Cardiology Journal. 2024. Vol. 29. No.11. P. 251-349. DOI: 10.15829/1560-4071-2024-6162.

25. Chronic heart failure in ischemic heart disease is a systemic microcirculatory pathology /V.V. Kilessa, N.V. Zhukova, E.A. Itskova [et al.] //Crimean Therapeutic Journal. 2024. No.3. Р.51-58.

26. Khudoerova D.R. Prognosis and prevention of diabetic nephropathy // Research Journal of Trauma and Disability Studies. 2023. Vol.2. No.4. P.75–84. Accessed March 4, 2025. https://journals.academiczone.net/index.php/rjtds/article/view/693

27. Shestakova M.V. Diabetes mellitus and chronic kidney disease: possibilities of prognosis, early diagnosis and nephroprotection in the 21st century // Therapeutic Archive. 2016. №6. pp.84-88. DOI: 10.17116/terarkh201688684-88

28. A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives /M. Evans, R.D. Lewis, A.R. Morgan [et al.]// Adv Ther. 2022. No.39 (1). P.33-43. DOI: 10.1007/s12325-021-01927-z.

29. Bronchial asthma is associated with increased risk of chronic kidney disease. / H.L. Huang, S.Y. Ho, C.H. Li et al. // BMC Pulm Med. 2014. Р.14-80. DOI:10.1186/1471-2466-14-80

30. Chronic Kidney Disease and Cancer: Inter-Relationships and Mechanisms /M. Hu, Q. Wang, B. Liu [et al.] // Frontiers in Cell and Developmental Biology. 2022. Vol.10. P.868715. DOI: 10.3389/fcell.2022.868715

31. Chronic Kidney Disease as a Comorbidity in Heart Failure / M. Szlagor, J. Dybiec, E. Młynarska [et al.] // International Journal of Molecular Sciences. 2023. Vol.24. No.3:2988. DOI: 10.3390/ijms24032988.

32. Chronic kidney disease: global dimension and perspectives./ V. Jha, G. Garcia-Garcia, K. Iseki et al. // Lancet. 2013. Vol.382. No.9888. Р.260-272. DOI:10.1016/S0140-6736(13)60687-X

33. Diabetic Retinopathy: A Position Statement by the American Diabetes Association /S. D. Solomon, E. Chew, E.J. Duh [et al.] // Diabetes Care. 2017. Vol.40. No.3. P.412–418. DOI: 10.2337/dc16-2641

34. Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial /j.A. Sparks, K.M.M. Vanni, M.A. Sparks [et al.] //journal of the American Society of Nephrology. 2021. Vol.32. No.12. P.3197-3207. DOI: 10.1681/ASN.2021050598.

35. Is There an Association Between Chronic Obstructive Pulmonary Disease and Chronic Renal Failure? / N. Maduros, S. Jarvis, A. Saleem [et al.] // Cureus: Journal of Medical Science. 2022. Vol.14. No.6: e26149. DOI:10.7759/cureus.26149

36. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney International. 2024. Vol. 105 (Suppl 4S), S117–S314. DOI: 10.1016/j.kint.2023.10.018. The link is active on 04/09/2025. https://congress-med.ru/assets/files/Полезная%20информация/2024/25.08.2024/2024-kdigo-rekomendaczii-po-xbp.pdf

37. The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes /j. S. Lees, B.M.P. Elyan, S.M. Herrmann [et al.] // Nephrol Dial Transplant. Vol. 38. No. 5. P.1071–1079. DOI: 10.1093/ndt/gfac011